Aspen's debtstands at R53.5bn, more than its R45.7bn market capitalisation.
A subscription gives you full digital access to all Sunday Times content.Registered on the BusinessLIVE, Business Day, Financial Mail or Rand Daily Mail websites? Sign in with the same details.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Aspen shares plunge 29% after disappointing resultsInvestors are concerned that the company’s borrowings, net of cash, have increased
Read more »
Aspen shares plunge on poor resultsAspen Pharmacare's shares plunged to a seven-year low on Friday as an already protracted deal to sell its infant-formula business dragged out even further, choking off cash flows and weighing on financing costs
Read more »
Aspen to split SA commercial pharmaceutical businessThe multinational drugmaker bids to strategically review its South African and European operations.
Read more »
MARKET WRAP: JSE’s three-week winning streak endsIt was a mixed day for corporate news with positive results from MMI, while Aspen and Tongaat both crashed 28%
Read more »
JSE poised for weak start to a busy day of company resultsStandard Bank Group, MTN, Sanlam and Aspen Pharmacare are four of the companies due to release results on Thursday
Read more »
Aspen shares plunge 29% after disappointing resultsInvestors are concerned that the company’s borrowings, net of cash, have increased
Read more »
Aspen’s shares halve after weak resultsInvestors are concerned that the company’s borrowings, net of cash, have increased
Read more »
Aspen shares plunge on poor resultsAspen Pharmacare's shares plunged to a seven-year low on Friday as an already protracted deal to sell its infant-formula business dragged out even further, choking off cash flows and weighing on financing costs
Read more »
Aspen to split SA commercial pharmaceutical businessThe multinational drugmaker bids to strategically review its South African and European operations.
Read more »